nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—malignant glioma	0.763	1	CbGaD
Telmisartan—Anxiety depression—Temozolomide—malignant glioma	0.0091	0.0669	CcSEcCtD
Telmisartan—Leg edema—Temozolomide—malignant glioma	0.00555	0.0408	CcSEcCtD
Telmisartan—Disorder sight—Temozolomide—malignant glioma	0.00314	0.0231	CcSEcCtD
Telmisartan—Haemorrhoids—Temozolomide—malignant glioma	0.00254	0.0187	CcSEcCtD
Telmisartan—Interstitial lung disease—Carmustine—malignant glioma	0.00218	0.0161	CcSEcCtD
Telmisartan—Interstitial lung disease—Temozolomide—malignant glioma	0.00211	0.0155	CcSEcCtD
Telmisartan—Lung disorder—Temozolomide—malignant glioma	0.00211	0.0155	CcSEcCtD
Telmisartan—Influenza-like symptoms—Temozolomide—malignant glioma	0.00209	0.0154	CcSEcCtD
Telmisartan—Abscess—Carmustine—malignant glioma	0.00195	0.0144	CcSEcCtD
Telmisartan—Otitis media—Temozolomide—malignant glioma	0.00192	0.0141	CcSEcCtD
Telmisartan—Rigors—Temozolomide—malignant glioma	0.00183	0.0135	CcSEcCtD
Telmisartan—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00158	0.0116	CcSEcCtD
Telmisartan—AGTR1—endothelium—malignant glioma	0.00155	0.139	CbGeAlD
Telmisartan—Vaginal inflammation—Temozolomide—malignant glioma	0.00149	0.011	CcSEcCtD
Telmisartan—Influenza like illness—Temozolomide—malignant glioma	0.00145	0.0107	CcSEcCtD
Telmisartan—AGTR1—blood vessel—malignant glioma	0.00143	0.128	CbGeAlD
Telmisartan—Vaginal infection—Temozolomide—malignant glioma	0.00141	0.0104	CcSEcCtD
Telmisartan—Abnormal vision—Carmustine—malignant glioma	0.00135	0.00991	CcSEcCtD
Telmisartan—Sepsis—Carmustine—malignant glioma	0.00134	0.00986	CcSEcCtD
Telmisartan—Abnormal vision—Temozolomide—malignant glioma	0.0013	0.00958	CcSEcCtD
Telmisartan—Diabetes mellitus—Carmustine—malignant glioma	0.00129	0.00949	CcSEcCtD
Telmisartan—PPARG—endothelium—malignant glioma	0.00128	0.114	CbGeAlD
Telmisartan—Ear pain—Temozolomide—malignant glioma	0.00127	0.00935	CcSEcCtD
Telmisartan—Gastroenteritis—Temozolomide—malignant glioma	0.00122	0.009	CcSEcCtD
Telmisartan—Vascular purpura—Temozolomide—malignant glioma	0.00121	0.00891	CcSEcCtD
Telmisartan—PPARG—blood vessel—malignant glioma	0.00118	0.105	CbGeAlD
Telmisartan—Purpura—Temozolomide—malignant glioma	0.00112	0.00827	CcSEcCtD
Telmisartan—Face oedema—Carmustine—malignant glioma	0.00108	0.00797	CcSEcCtD
Telmisartan—Face oedema—Temozolomide—malignant glioma	0.00105	0.0077	CcSEcCtD
Telmisartan—Hypokalaemia—Carmustine—malignant glioma	0.00102	0.00751	CcSEcCtD
Telmisartan—Dry skin—Temozolomide—malignant glioma	0.000994	0.00731	CcSEcCtD
Telmisartan—Muscular weakness—Carmustine—malignant glioma	0.000989	0.00728	CcSEcCtD
Telmisartan—Hypokalaemia—Temozolomide—malignant glioma	0.000987	0.00726	CcSEcCtD
Telmisartan—Breast disorder—Temozolomide—malignant glioma	0.00098	0.00721	CcSEcCtD
Telmisartan—Muscular weakness—Temozolomide—malignant glioma	0.000956	0.00703	CcSEcCtD
Telmisartan—Abdominal distension—Temozolomide—malignant glioma	0.000943	0.00694	CcSEcCtD
Telmisartan—Sweating increased—Temozolomide—malignant glioma	0.000913	0.00671	CcSEcCtD
Telmisartan—Bronchitis—Temozolomide—malignant glioma	0.000901	0.00663	CcSEcCtD
Telmisartan—Dysuria—Temozolomide—malignant glioma	0.000876	0.00645	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000871	0.00641	CcSEcCtD
Telmisartan—Pneumonia—Carmustine—malignant glioma	0.00087	0.0064	CcSEcCtD
Telmisartan—Pollakiuria—Temozolomide—malignant glioma	0.000866	0.00637	CcSEcCtD
Telmisartan—Erectile dysfunction—Temozolomide—malignant glioma	0.000863	0.00635	CcSEcCtD
Telmisartan—Depression—Carmustine—malignant glioma	0.000862	0.00634	CcSEcCtD
Telmisartan—Renal failure—Carmustine—malignant glioma	0.00085	0.00625	CcSEcCtD
Telmisartan—Neuropathy peripheral—Carmustine—malignant glioma	0.000847	0.00623	CcSEcCtD
Telmisartan—Urinary tract infection—Carmustine—malignant glioma	0.00084	0.00618	CcSEcCtD
Telmisartan—Pneumonia—Temozolomide—malignant glioma	0.00084	0.00618	CcSEcCtD
Telmisartan—Infestation—Temozolomide—malignant glioma	0.000836	0.00615	CcSEcCtD
Telmisartan—Infestation NOS—Temozolomide—malignant glioma	0.000836	0.00615	CcSEcCtD
Telmisartan—Depression—Temozolomide—malignant glioma	0.000833	0.00613	CcSEcCtD
Telmisartan—Neuropathy peripheral—Temozolomide—malignant glioma	0.000819	0.00602	CcSEcCtD
Telmisartan—Urinary tract infection—Temozolomide—malignant glioma	0.000812	0.00597	CcSEcCtD
Telmisartan—Hepatobiliary disease—Temozolomide—malignant glioma	0.00079	0.00581	CcSEcCtD
Telmisartan—Sinusitis—Temozolomide—malignant glioma	0.000784	0.00577	CcSEcCtD
Telmisartan—Hypoaesthesia—Carmustine—malignant glioma	0.000772	0.00568	CcSEcCtD
Telmisartan—Oedema peripheral—Carmustine—malignant glioma	0.000765	0.00562	CcSEcCtD
Telmisartan—Connective tissue disorder—Carmustine—malignant glioma	0.000763	0.00561	CcSEcCtD
Telmisartan—Visual impairment—Carmustine—malignant glioma	0.000748	0.0055	CcSEcCtD
Telmisartan—Hypoaesthesia—Temozolomide—malignant glioma	0.000746	0.00549	CcSEcCtD
Telmisartan—Pharyngitis—Temozolomide—malignant glioma	0.000744	0.00548	CcSEcCtD
Telmisartan—Urinary tract disorder—Temozolomide—malignant glioma	0.000741	0.00545	CcSEcCtD
Telmisartan—Oedema peripheral—Temozolomide—malignant glioma	0.000739	0.00543	CcSEcCtD
Telmisartan—Connective tissue disorder—Temozolomide—malignant glioma	0.000737	0.00542	CcSEcCtD
Telmisartan—Urethral disorder—Temozolomide—malignant glioma	0.000735	0.00541	CcSEcCtD
Telmisartan—Eye disorder—Carmustine—malignant glioma	0.000725	0.00533	CcSEcCtD
Telmisartan—Visual impairment—Temozolomide—malignant glioma	0.000723	0.00532	CcSEcCtD
Telmisartan—Flushing—Carmustine—malignant glioma	0.00072	0.0053	CcSEcCtD
Telmisartan—PPARG—embryo—malignant glioma	0.000702	0.0629	CbGeAlD
Telmisartan—Eye disorder—Temozolomide—malignant glioma	0.000701	0.00516	CcSEcCtD
Telmisartan—Tinnitus—Temozolomide—malignant glioma	0.000699	0.00514	CcSEcCtD
Telmisartan—Cardiac disorder—Temozolomide—malignant glioma	0.000696	0.00512	CcSEcCtD
Telmisartan—Flushing—Temozolomide—malignant glioma	0.000696	0.00512	CcSEcCtD
Telmisartan—Arrhythmia—Carmustine—malignant glioma	0.000693	0.0051	CcSEcCtD
Telmisartan—Angiopathy—Temozolomide—malignant glioma	0.00068	0.00501	CcSEcCtD
Telmisartan—Mental disorder—Carmustine—malignant glioma	0.00068	0.005	CcSEcCtD
Telmisartan—Immune system disorder—Temozolomide—malignant glioma	0.000677	0.00498	CcSEcCtD
Telmisartan—Mediastinal disorder—Temozolomide—malignant glioma	0.000676	0.00497	CcSEcCtD
Telmisartan—Erythema—Carmustine—malignant glioma	0.000676	0.00497	CcSEcCtD
Telmisartan—Malnutrition—Carmustine—malignant glioma	0.000676	0.00497	CcSEcCtD
Telmisartan—Chills—Temozolomide—malignant glioma	0.000673	0.00495	CcSEcCtD
Telmisartan—Mental disorder—Temozolomide—malignant glioma	0.000657	0.00483	CcSEcCtD
Telmisartan—Back pain—Carmustine—malignant glioma	0.000654	0.00481	CcSEcCtD
Telmisartan—Erythema—Temozolomide—malignant glioma	0.000653	0.0048	CcSEcCtD
Telmisartan—Malnutrition—Temozolomide—malignant glioma	0.000653	0.0048	CcSEcCtD
Telmisartan—Dysgeusia—Temozolomide—malignant glioma	0.000639	0.0047	CcSEcCtD
Telmisartan—Back pain—Temozolomide—malignant glioma	0.000632	0.00465	CcSEcCtD
Telmisartan—Anaemia—Carmustine—malignant glioma	0.000624	0.00459	CcSEcCtD
Telmisartan—Ill-defined disorder—Temozolomide—malignant glioma	0.000606	0.00446	CcSEcCtD
Telmisartan—Anaemia—Temozolomide—malignant glioma	0.000603	0.00444	CcSEcCtD
Telmisartan—Angioedema—Temozolomide—malignant glioma	0.000597	0.00439	CcSEcCtD
Telmisartan—Malaise—Temozolomide—malignant glioma	0.000589	0.00433	CcSEcCtD
Telmisartan—Vertigo—Temozolomide—malignant glioma	0.000587	0.00431	CcSEcCtD
Telmisartan—Hypertension—Carmustine—malignant glioma	0.000583	0.00429	CcSEcCtD
Telmisartan—Palpitations—Temozolomide—malignant glioma	0.000577	0.00424	CcSEcCtD
Telmisartan—Chest pain—Carmustine—malignant glioma	0.000575	0.00423	CcSEcCtD
Telmisartan—Myalgia—Carmustine—malignant glioma	0.000575	0.00423	CcSEcCtD
Telmisartan—Anxiety—Carmustine—malignant glioma	0.000573	0.00422	CcSEcCtD
Telmisartan—Cough—Temozolomide—malignant glioma	0.00057	0.00419	CcSEcCtD
Telmisartan—Hypertension—Temozolomide—malignant glioma	0.000564	0.00415	CcSEcCtD
Telmisartan—Myalgia—Temozolomide—malignant glioma	0.000556	0.00409	CcSEcCtD
Telmisartan—Arthralgia—Temozolomide—malignant glioma	0.000556	0.00409	CcSEcCtD
Telmisartan—Anxiety—Temozolomide—malignant glioma	0.000554	0.00407	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000552	0.00406	CcSEcCtD
Telmisartan—Oedema—Carmustine—malignant glioma	0.000551	0.00406	CcSEcCtD
Telmisartan—Discomfort—Temozolomide—malignant glioma	0.000549	0.00404	CcSEcCtD
Telmisartan—Infection—Carmustine—malignant glioma	0.000548	0.00403	CcSEcCtD
Telmisartan—AGTR1—medulla oblongata—malignant glioma	0.000545	0.0488	CbGeAlD
Telmisartan—Dry mouth—Temozolomide—malignant glioma	0.000544	0.004	CcSEcCtD
Telmisartan—Thrombocytopenia—Carmustine—malignant glioma	0.00054	0.00397	CcSEcCtD
Telmisartan—Tachycardia—Carmustine—malignant glioma	0.000538	0.00396	CcSEcCtD
Telmisartan—Anaphylactic shock—Temozolomide—malignant glioma	0.000533	0.00392	CcSEcCtD
Telmisartan—Oedema—Temozolomide—malignant glioma	0.000533	0.00392	CcSEcCtD
Telmisartan—Infection—Temozolomide—malignant glioma	0.000529	0.00389	CcSEcCtD
Telmisartan—Anorexia—Carmustine—malignant glioma	0.000526	0.00387	CcSEcCtD
Telmisartan—Nervous system disorder—Temozolomide—malignant glioma	0.000523	0.00384	CcSEcCtD
Telmisartan—Thrombocytopenia—Temozolomide—malignant glioma	0.000522	0.00384	CcSEcCtD
Telmisartan—Skin disorder—Temozolomide—malignant glioma	0.000518	0.00381	CcSEcCtD
Telmisartan—Hypotension—Carmustine—malignant glioma	0.000515	0.00379	CcSEcCtD
Telmisartan—Hyperhidrosis—Temozolomide—malignant glioma	0.000515	0.00379	CcSEcCtD
Telmisartan—Anorexia—Temozolomide—malignant glioma	0.000508	0.00374	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000502	0.0037	CcSEcCtD
Telmisartan—Insomnia—Carmustine—malignant glioma	0.000499	0.00367	CcSEcCtD
Telmisartan—Paraesthesia—Carmustine—malignant glioma	0.000495	0.00364	CcSEcCtD
Telmisartan—Dyspnoea—Carmustine—malignant glioma	0.000492	0.00362	CcSEcCtD
Telmisartan—Somnolence—Carmustine—malignant glioma	0.00049	0.00361	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000485	0.00357	CcSEcCtD
Telmisartan—Insomnia—Temozolomide—malignant glioma	0.000482	0.00354	CcSEcCtD
Telmisartan—Decreased appetite—Carmustine—malignant glioma	0.000479	0.00353	CcSEcCtD
Telmisartan—Paraesthesia—Temozolomide—malignant glioma	0.000478	0.00352	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Carmustine—malignant glioma	0.000476	0.0035	CcSEcCtD
Telmisartan—Dyspnoea—Temozolomide—malignant glioma	0.000475	0.00349	CcSEcCtD
Telmisartan—Somnolence—Temozolomide—malignant glioma	0.000474	0.00348	CcSEcCtD
Telmisartan—Pain—Carmustine—malignant glioma	0.000472	0.00347	CcSEcCtD
Telmisartan—Constipation—Carmustine—malignant glioma	0.000472	0.00347	CcSEcCtD
Telmisartan—Dyspepsia—Temozolomide—malignant glioma	0.000469	0.00345	CcSEcCtD
Telmisartan—Decreased appetite—Temozolomide—malignant glioma	0.000463	0.00341	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00046	0.00338	CcSEcCtD
Telmisartan—Fatigue—Temozolomide—malignant glioma	0.000459	0.00338	CcSEcCtD
Telmisartan—Pain—Temozolomide—malignant glioma	0.000456	0.00335	CcSEcCtD
Telmisartan—Constipation—Temozolomide—malignant glioma	0.000456	0.00335	CcSEcCtD
Telmisartan—Feeling abnormal—Carmustine—malignant glioma	0.000454	0.00334	CcSEcCtD
Telmisartan—Gastrointestinal pain—Carmustine—malignant glioma	0.000451	0.00332	CcSEcCtD
Telmisartan—Feeling abnormal—Temozolomide—malignant glioma	0.000439	0.00323	CcSEcCtD
Telmisartan—Abdominal pain—Carmustine—malignant glioma	0.000436	0.00321	CcSEcCtD
Telmisartan—Body temperature increased—Carmustine—malignant glioma	0.000436	0.00321	CcSEcCtD
Telmisartan—Gastrointestinal pain—Temozolomide—malignant glioma	0.000436	0.00321	CcSEcCtD
Telmisartan—Urticaria—Temozolomide—malignant glioma	0.000423	0.00311	CcSEcCtD
Telmisartan—Abdominal pain—Temozolomide—malignant glioma	0.000421	0.0031	CcSEcCtD
Telmisartan—Body temperature increased—Temozolomide—malignant glioma	0.000421	0.0031	CcSEcCtD
Telmisartan—Hypersensitivity—Carmustine—malignant glioma	0.000406	0.00299	CcSEcCtD
Telmisartan—Asthenia—Carmustine—malignant glioma	0.000396	0.00291	CcSEcCtD
Telmisartan—AGTR1—central nervous system—malignant glioma	0.000395	0.0353	CbGeAlD
Telmisartan—Hypersensitivity—Temozolomide—malignant glioma	0.000393	0.00289	CcSEcCtD
Telmisartan—Asthenia—Temozolomide—malignant glioma	0.000382	0.00281	CcSEcCtD
Telmisartan—Diarrhoea—Carmustine—malignant glioma	0.000377	0.00278	CcSEcCtD
Telmisartan—Pruritus—Temozolomide—malignant glioma	0.000377	0.00277	CcSEcCtD
Telmisartan—ABCB1—blood vessel—malignant glioma	0.000372	0.0333	CbGeAlD
Telmisartan—Candesartan—PTGS1—malignant glioma	0.000368	1	CrCbGaD
Telmisartan—ABCG2—telencephalon—malignant glioma	0.000366	0.0328	CbGeAlD
Telmisartan—Dizziness—Carmustine—malignant glioma	0.000365	0.00268	CcSEcCtD
Telmisartan—Diarrhoea—Temozolomide—malignant glioma	0.000365	0.00268	CcSEcCtD
Telmisartan—Dizziness—Temozolomide—malignant glioma	0.000352	0.00259	CcSEcCtD
Telmisartan—Vomiting—Carmustine—malignant glioma	0.000351	0.00258	CcSEcCtD
Telmisartan—Rash—Carmustine—malignant glioma	0.000348	0.00256	CcSEcCtD
Telmisartan—Dermatitis—Carmustine—malignant glioma	0.000347	0.00255	CcSEcCtD
Telmisartan—Headache—Carmustine—malignant glioma	0.000345	0.00254	CcSEcCtD
Telmisartan—Vomiting—Temozolomide—malignant glioma	0.000339	0.00249	CcSEcCtD
Telmisartan—Rash—Temozolomide—malignant glioma	0.000336	0.00247	CcSEcCtD
Telmisartan—Dermatitis—Temozolomide—malignant glioma	0.000336	0.00247	CcSEcCtD
Telmisartan—Headache—Temozolomide—malignant glioma	0.000334	0.00246	CcSEcCtD
Telmisartan—Nausea—Carmustine—malignant glioma	0.000328	0.00241	CcSEcCtD
Telmisartan—PPARG—central nervous system—malignant glioma	0.000325	0.0291	CbGeAlD
Telmisartan—Nausea—Temozolomide—malignant glioma	0.000317	0.00233	CcSEcCtD
Telmisartan—AGTR1—brain—malignant glioma	0.000313	0.0281	CbGeAlD
Telmisartan—ABCG2—medulla oblongata—malignant glioma	0.000288	0.0258	CbGeAlD
Telmisartan—ABCG2—midbrain—malignant glioma	0.000263	0.0235	CbGeAlD
Telmisartan—PPARG—brain—malignant glioma	0.000258	0.0231	CbGeAlD
Telmisartan—ABCG2—spinal cord—malignant glioma	0.000256	0.023	CbGeAlD
Telmisartan—ABCB1—embryo—malignant glioma	0.000222	0.0199	CbGeAlD
Telmisartan—ABCG2—cerebellum—malignant glioma	0.000203	0.0182	CbGeAlD
Telmisartan—ABCB1—retina—malignant glioma	0.000196	0.0176	CbGeAlD
Telmisartan—ABCB1—telencephalon—malignant glioma	0.00018	0.0162	CbGeAlD
Telmisartan—ABCG2—brain—malignant glioma	0.000165	0.0148	CbGeAlD
Telmisartan—ABCB1—medulla oblongata—malignant glioma	0.000142	0.0127	CbGeAlD
Telmisartan—ABCB1—midbrain—malignant glioma	0.00013	0.0116	CbGeAlD
Telmisartan—ABCB1—spinal cord—malignant glioma	0.000126	0.0113	CbGeAlD
Telmisartan—ABCB1—central nervous system—malignant glioma	0.000103	0.00919	CbGeAlD
Telmisartan—ABCB1—cerebellum—malignant glioma	0.0001	0.00898	CbGeAlD
Telmisartan—ABCB1—brain—malignant glioma	8.14e-05	0.00729	CbGeAlD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.22e-05	0.000582	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.17e-05	0.000576	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH3—malignant glioma	5.06e-05	0.000564	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—IDH2—malignant glioma	4.99e-05	0.000557	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—malignant glioma	4.98e-05	0.000556	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS1—malignant glioma	4.96e-05	0.000553	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.94e-05	0.000551	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT2—malignant glioma	4.91e-05	0.000548	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.79e-05	0.000535	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—malignant glioma	4.76e-05	0.000531	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—H3F3A—malignant glioma	4.7e-05	0.000525	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—malignant glioma	4.7e-05	0.000524	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2B6—malignant glioma	4.69e-05	0.000524	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.67e-05	0.000521	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—F2—malignant glioma	4.67e-05	0.000521	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCR3—malignant glioma	4.66e-05	0.00052	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—BCHE—malignant glioma	4.61e-05	0.000514	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC5A5—malignant glioma	4.55e-05	0.000508	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH2—malignant glioma	4.54e-05	0.000506	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—YWHAE—malignant glioma	4.53e-05	0.000506	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK2—malignant glioma	4.53e-05	0.000506	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.53e-05	0.000505	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—FGF2—malignant glioma	4.52e-05	0.000504	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTT1—malignant glioma	4.51e-05	0.000504	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FLT1—malignant glioma	4.51e-05	0.000503	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—DUSP6—malignant glioma	4.49e-05	0.000501	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.47e-05	0.000499	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CG—malignant glioma	4.47e-05	0.000499	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAG1—malignant glioma	4.44e-05	0.000495	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH3—malignant glioma	4.42e-05	0.000493	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FBXW7—malignant glioma	4.35e-05	0.000485	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.31e-05	0.00048	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—IDH1—malignant glioma	4.29e-05	0.000479	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—COX8A—malignant glioma	4.29e-05	0.000479	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.27e-05	0.000476	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BDKRB2—malignant glioma	4.26e-05	0.000475	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—F2—malignant glioma	4.24e-05	0.000473	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS1—malignant glioma	4.23e-05	0.000472	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.21e-05	0.00047	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RAF1—malignant glioma	4.21e-05	0.00047	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—malignant glioma	4.19e-05	0.000468	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—COX8A—malignant glioma	4.19e-05	0.000467	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ERBB2—malignant glioma	4.17e-05	0.000465	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SPHK1—malignant glioma	4.15e-05	0.000463	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT2—malignant glioma	4.09e-05	0.000456	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2C18—malignant glioma	4.07e-05	0.000454	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CG—malignant glioma	4.06e-05	0.000453	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	4.04e-05	0.000451	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTPN11—malignant glioma	3.99e-05	0.000445	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH2—malignant glioma	3.96e-05	0.000442	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—BCHE—malignant glioma	3.93e-05	0.000439	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CD—malignant glioma	3.93e-05	0.000438	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CDKN2B—malignant glioma	3.9e-05	0.000435	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC5A5—malignant glioma	3.88e-05	0.000433	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KNG1—malignant glioma	3.88e-05	0.000432	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.84e-05	0.000428	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.81e-05	0.000425	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.72e-05	0.000415	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT2—malignant glioma	3.71e-05	0.000414	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NCOR1—malignant glioma	3.7e-05	0.000412	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK1—malignant glioma	3.7e-05	0.000412	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.67e-05	0.00041	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTP1—malignant glioma	3.67e-05	0.000409	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ASMT—malignant glioma	3.65e-05	0.000407	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.64e-05	0.000406	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.62e-05	0.000403	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—malignant glioma	3.58e-05	0.000399	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CD—malignant glioma	3.57e-05	0.000398	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CAT—malignant glioma	3.57e-05	0.000398	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.57e-05	0.000398	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.56e-05	0.000398	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ASMT—malignant glioma	3.56e-05	0.000397	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	3.56e-05	0.000397	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.55e-05	0.000396	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.51e-05	0.000392	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	3.44e-05	0.000383	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP3—malignant glioma	3.44e-05	0.000383	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCAN—malignant glioma	3.43e-05	0.000383	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CB—malignant glioma	3.43e-05	0.000382	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN2B—malignant glioma	3.41e-05	0.00038	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NCOR1—malignant glioma	3.37e-05	0.000376	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCAN—malignant glioma	3.35e-05	0.000374	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTK2—malignant glioma	3.31e-05	0.000369	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—malignant glioma	3.29e-05	0.000367	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTT1—malignant glioma	3.29e-05	0.000367	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.27e-05	0.000365	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HES1—malignant glioma	3.25e-05	0.000362	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NCOR1—malignant glioma	3.23e-05	0.00036	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—malignant glioma	3.21e-05	0.000358	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.19e-05	0.000356	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RAF1—malignant glioma	3.19e-05	0.000355	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—malignant glioma	3.18e-05	0.000355	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.17e-05	0.000354	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—malignant glioma	3.15e-05	0.000351	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—malignant glioma	3.14e-05	0.00035	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—malignant glioma	3.13e-05	0.000349	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.11e-05	0.000347	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—malignant glioma	3.11e-05	0.000347	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFRA—malignant glioma	3.09e-05	0.000345	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS1—malignant glioma	3.08e-05	0.000344	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAT—malignant glioma	3.05e-05	0.00034	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SPP1—malignant glioma	3e-05	0.000335	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	3e-05	0.000335	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3e-05	0.000334	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—malignant glioma	2.99e-05	0.000333	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—malignant glioma	2.89e-05	0.000322	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NCOR1—malignant glioma	2.88e-05	0.000321	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—BCHE—malignant glioma	2.87e-05	0.00032	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—malignant glioma	2.86e-05	0.000319	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—malignant glioma	2.85e-05	0.000317	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC5A5—malignant glioma	2.83e-05	0.000316	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH1—malignant glioma	2.81e-05	0.000313	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFB—malignant glioma	2.78e-05	0.00031	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—IDH2—malignant glioma	2.77e-05	0.000308	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGFR1—malignant glioma	2.76e-05	0.000308	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—malignant glioma	2.75e-05	0.000307	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CAV1—malignant glioma	2.75e-05	0.000306	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—malignant glioma	2.73e-05	0.000304	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—malignant glioma	2.72e-05	0.000304	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.71e-05	0.000302	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—IDH2—malignant glioma	2.7e-05	0.000301	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CAV1—malignant glioma	2.63e-05	0.000294	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.62e-05	0.000293	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.61e-05	0.000291	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.61e-05	0.000291	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—malignant glioma	2.6e-05	0.00029	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.6e-05	0.00029	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2B6—malignant glioma	2.54e-05	0.000283	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FN1—malignant glioma	2.51e-05	0.000279	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—F2—malignant glioma	2.51e-05	0.000279	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—malignant glioma	2.5e-05	0.000279	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.49e-05	0.000278	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BAD—malignant glioma	2.48e-05	0.000276	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—malignant glioma	2.45e-05	0.000274	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.44e-05	0.000272	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—malignant glioma	2.42e-05	0.000269	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD80—malignant glioma	2.4e-05	0.000268	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—malignant glioma	2.4e-05	0.000267	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—malignant glioma	2.4e-05	0.000267	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—IDH1—malignant glioma	2.38e-05	0.000265	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGF—malignant glioma	2.37e-05	0.000264	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTPN11—malignant glioma	2.36e-05	0.000263	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAV1—malignant glioma	2.34e-05	0.000261	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—IDH1—malignant glioma	2.32e-05	0.000259	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.32e-05	0.000259	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.3e-05	0.000257	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SPHK1—malignant glioma	2.3e-05	0.000257	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—malignant glioma	2.28e-05	0.000254	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.25e-05	0.000251	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—malignant glioma	2.25e-05	0.000251	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SPHK1—malignant glioma	2.25e-05	0.000251	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.24e-05	0.00025	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAT—malignant glioma	2.22e-05	0.000248	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2C18—malignant glioma	2.2e-05	0.000245	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—malignant glioma	2.2e-05	0.000245	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT2—malignant glioma	2.19e-05	0.000245	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—malignant glioma	2.18e-05	0.000244	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—malignant glioma	2.14e-05	0.000238	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.13e-05	0.000237	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.11e-05	0.000236	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—malignant glioma	2.11e-05	0.000235	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NCOR1—malignant glioma	2.1e-05	0.000234	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—malignant glioma	2.09e-05	0.000233	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—malignant glioma	2.06e-05	0.00023	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—malignant glioma	2.05e-05	0.000228	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.05e-05	0.000228	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF2—malignant glioma	2.02e-05	0.000225	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.94e-05	0.000216	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—malignant glioma	1.92e-05	0.000214	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—malignant glioma	1.9e-05	0.000212	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—malignant glioma	1.9e-05	0.000211	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—malignant glioma	1.89e-05	0.000211	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAF1—malignant glioma	1.88e-05	0.00021	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—malignant glioma	1.88e-05	0.000209	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.87e-05	0.000208	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—malignant glioma	1.86e-05	0.000208	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—malignant glioma	1.84e-05	0.000205	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—malignant glioma	1.82e-05	0.000203	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—malignant glioma	1.78e-05	0.000198	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—malignant glioma	1.77e-05	0.000197	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.73e-05	0.000193	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAV1—malignant glioma	1.71e-05	0.000191	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS1—malignant glioma	1.71e-05	0.000191	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—malignant glioma	1.71e-05	0.00019	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.7e-05	0.00019	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—malignant glioma	1.69e-05	0.000189	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—malignant glioma	1.69e-05	0.000188	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS1—malignant glioma	1.67e-05	0.000186	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—malignant glioma	1.66e-05	0.000185	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—malignant glioma	1.64e-05	0.000182	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—malignant glioma	1.62e-05	0.000181	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—malignant glioma	1.6e-05	0.000178	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCHE—malignant glioma	1.59e-05	0.000177	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—malignant glioma	1.59e-05	0.000177	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.57e-05	0.000175	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—malignant glioma	1.56e-05	0.000174	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCHE—malignant glioma	1.55e-05	0.000173	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—malignant glioma	1.55e-05	0.000173	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—malignant glioma	1.53e-05	0.000171	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—malignant glioma	1.51e-05	0.000169	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—malignant glioma	1.5e-05	0.000168	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.48e-05	0.000165	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.47e-05	0.000164	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—malignant glioma	1.43e-05	0.00016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—malignant glioma	1.42e-05	0.000158	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—malignant glioma	1.41e-05	0.000158	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.41e-05	0.000157	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—malignant glioma	1.37e-05	0.000153	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—malignant glioma	1.32e-05	0.000147	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—malignant glioma	1.29e-05	0.000144	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.28e-05	0.000143	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—malignant glioma	1.26e-05	0.000141	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—malignant glioma	1.23e-05	0.000138	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAT—malignant glioma	1.23e-05	0.000137	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—malignant glioma	1.22e-05	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAT—malignant glioma	1.2e-05	0.000134	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—malignant glioma	1.19e-05	0.000133	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—malignant glioma	1.18e-05	0.000132	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—malignant glioma	1.17e-05	0.00013	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOR1—malignant glioma	1.16e-05	0.00013	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOR1—malignant glioma	1.13e-05	0.000126	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—malignant glioma	1.12e-05	0.000125	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—malignant glioma	1.08e-05	0.000121	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—malignant glioma	1.05e-05	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—malignant glioma	1.03e-05	0.000115	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—malignant glioma	9.97e-06	0.000111	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—malignant glioma	9.55e-06	0.000107	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAV1—malignant glioma	9.47e-06	0.000106	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAV1—malignant glioma	9.24e-06	0.000103	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—malignant glioma	9.15e-06	0.000102	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.05e-06	0.000101	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—malignant glioma	8.62e-06	9.62e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—malignant glioma	8.42e-06	9.39e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—malignant glioma	8.32e-06	9.28e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—malignant glioma	8.15e-06	9.09e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—malignant glioma	8.12e-06	9.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—malignant glioma	7.58e-06	8.46e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—malignant glioma	7.4e-06	8.25e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—malignant glioma	7.27e-06	8.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—malignant glioma	6.61e-06	7.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—malignant glioma	6.55e-06	7.3e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—malignant glioma	6.45e-06	7.19e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—malignant glioma	6.39e-06	7.13e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—malignant glioma	5.94e-06	6.63e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—malignant glioma	5.71e-06	6.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—malignant glioma	5.57e-06	6.22e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.03e-06	4.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—malignant glioma	3.93e-06	4.39e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—malignant glioma	3.29e-06	3.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—malignant glioma	3.21e-06	3.58e-05	CbGpPWpGaD
